Stephen Shiao: Clinical Trials

3 trials sponsored by Stephen Shiao, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Active not recruiting 1
Phase 11Active not recruiting 1

Follow Stephen Shiao: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation
Pembrolizumab, Radiotherapy, Axatilimab - TNBC - Triple-Negative Breast Cancer, Breast Cancer
Phase 2RecruitingStephen Shiao342026-12-012026-11-16
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
Pembrolizumab, Radiation Therapy, Axatilimab - TNBC - Triple-Negative Breast Cancer, Breast Cancer
Phase 2RecruitingStephen Shiao352023-11-172026-11-16
Breast Cancer Study of Preoperative Pembrolizumab + Radiation
Pembrolizumab, RT Boost - Breast Cancer
Phase 1 / Phase 2Active not recruitingStephen Shiao662017-12-222026-04-20

Conditions studied

Breast Neoplasms (3)  ·  Triple Negative Breast Neoplasms (3)

Interventions

pembrolizumab (3)  ·  Radiotherapy (2)  ·  axatilimab (2)

Countries

United States (3)

Top investigators

Stephen L Shiao, MD, PhD (1)

Results publications

PMID 39298718